What Researchers Did
Researchers described a case of a paediatric patient with severe hidradenitis suppurativa successfully treated with combination high-dose ustekinumab and hyperbaric oxygen therapy.
What They Found
They found that a paediatric patient with severe hidradenitis suppurativa experienced successful treatment with a combination of high-dose ustekinumab and hyperbaric oxygen therapy. The patient's inflammatory nodules and associated pain improved, demonstrating a positive response to this novel combined approach.
Canadian Relevance
This study has no direct Canadian connection as it was not conducted in Canada nor involved Canadian researchers or patients.
Study Limitations
The primary limitation of this study is its design as a single case report, which prevents generalization of findings to a broader patient population.